Patent details

EP4288036 Title: FORMULATIONS OF A PLASMA KALLIKREIN INHIBITOR

Basic Information

Publication number:
EP4288036
PCT Application Number:
GB2023051120
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP237229299
PCT Publication Number:
WO2023209381
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF A PLASMA KALLIKREIN INHIBITOR
French Title of Invention:
FORMULATIONS D'UN INHIBITEUR DE LA KALLICRÉINE PLASMATIQUE
German Title of Invention:
FORMULIERUNGEN EINES PLASMAKALLIKREINHEMMERS
SPC Number:

Dates

Filing date:
27/04/2023
Grant date:
07/08/2024
EP Publication Date:
13/12/2023
PCT Publication Date:
02/11/2023
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2024
EP B1 Publication Date:
07/08/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/04/2043
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2024
 
 

Name:
Kalvista Pharmaceuticals Limited
Address:
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/08/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SMITH, Michael David
Address:
United States (US)

2

Name:
COOPER, John Alexander
Address:
United Kingdom (GB)

3

Name:
CROADSHAW, Oliver William
Address:
United Kingdom (GB)

4

Name:
ARROYO, Ana Catalina Ferreira
Address:
United States (US)

5

Name:
SCHIANO, Serena
Address:
United Kingdom (GB)

6

Name:
IVERSON, Matthew Scott
Address:
United States (US)

Priority

Priority Number:
202263335387 P
Priority Date:
27/04/2022
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202432
Publication date:
07/08/2024
Description:
Grant (B1)

2

Issue number:
202437
Publication date:
11/09/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
4
Annual Fee Amount:
41 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/04/2025
Last Annual Fee Paid Number:
3
Last Annual Fee Paid Amount:
33 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
09/08/2024 Power Of Attorney 1
09/08/2024 Outgoing Correspondence 1